News Chart LifeTech Scientific Corporation

Equities

Delayed Hong Kong S.E. Other stock markets 03:53:15 06/06/2024 BST			5-day change	1st Jan Change
1.62 ^HKD	0.00%		-3.57%	-31.06%

05-16	LifeTech Scientific Completes Follow-up of Phase 2 Clinical Study of IBS Coronary Scaffold	MT
05-15	LifeTech Scientific Corporation Announces One-Year Follow-Up Results of Phase II Clinical Study of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System	CI

6f1b6481f4.iT-JBQ0CzVLUCiQb2RO4zZchzm9Xn2IwiNOJbeu_s2Y.-gf6b1dTuxelWU4rqGrivKdghVp62j1c-v7uN4Tr_Ve8CLhtaE6JHLF4bQ~54731ce0653b145e364ceeb52c1fe094